Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

385 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
Hoellein A, Fallahi M, Schoeffmann S, Steidle S, Schaub FX, Rudelius M, Laitinen I, Nilsson L, Goga A, Peschel C, Nilsson JA, Cleveland JL, Keller U. Hoellein A, et al. Blood. 2014 Sep 25;124(13):2081-90. doi: 10.1182/blood-2014-06-584524. Epub 2014 Aug 20. Blood. 2014. PMID: 25143484 Free PMC article.
The Bcl10/Malt1 signaling pathway as a drug target in lymphoma.
Jost P, Peschel C, Ruland J. Jost P, et al. Curr Drug Targets. 2006 Oct;7(10):1335-40. doi: 10.2174/138945006778559256. Curr Drug Targets. 2006. PMID: 17073595 Review.
385 results
Jump to page
Feedback